https://scholars.lib.ntu.edu.tw/handle/123456789/637166
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Tseng, Ping-Tao | en_US |
dc.contributor.author | Zeng, Bing-Syuan | en_US |
dc.contributor.author | Thompson, Trevor | en_US |
dc.contributor.author | Stubbs, Brendon | en_US |
dc.contributor.author | PO-REN HSUEH | en_US |
dc.contributor.author | Su, Kuan-Pin | en_US |
dc.contributor.author | Chen, Yen-Wen | en_US |
dc.contributor.author | Chen, Tien-Yu | en_US |
dc.contributor.author | Wu, Yi-Cheng | en_US |
dc.contributor.author | Lin, Pao-Yen | en_US |
dc.contributor.author | Carvalho, Andre F | en_US |
dc.contributor.author | Hsu, Chih-Wei | en_US |
dc.contributor.author | Li, Dian-Jeng | en_US |
dc.contributor.author | Yeh, Ta-Chuan | en_US |
dc.contributor.author | Sun, Cheuk-Kwan | en_US |
dc.contributor.author | Cheng, Yu-Shian | en_US |
dc.contributor.author | Shiue, Yow-Ling | en_US |
dc.contributor.author | Liang, Chih-Sung | en_US |
dc.contributor.author | YU-KANG TU | en_US |
dc.date.accessioned | 2023-11-16T02:24:07Z | - |
dc.date.available | 2023-11-16T02:24:07Z | - |
dc.date.issued | 2023-08-30 | - |
dc.identifier.issn | 13231316 | - |
dc.identifier.uri | https://scholars.lib.ntu.edu.tw/handle/123456789/637166 | - |
dc.description.abstract | Many randomized controlled trials (RCTs) have investigated the use of interleukin 6 antagonists for the treatment of coronavirus disease 2019 (COVID-19), yielding inconsistent results. This network meta-analysis (NMA) aimed to identify the source of these inconsistent results by reassessing whether participants treated with standard of care (SoC) plus placebo have different all-cause mortality from those treated with SoC alone and to reevaluate the efficacy of interleukin 6 antagonists in the treatment of COVID-19. | en_US |
dc.language.iso | en | en_US |
dc.relation.ispartof | Psychiatry and clinical neurosciences | en_US |
dc.subject | COVID-19; coronavirus disease 2019; interleukin 6; network meta-analysis; placebo effect | en_US |
dc.title | Placebo effects on all-cause mortality of patients with COVID-19 in randomized controlled trials of interleukin 6 antagonists: A systematic review and network meta-analysis | en_US |
dc.type | journal article | en |
dc.identifier.doi | 10.1111/pcn.13592 | - |
dc.identifier.pmid | 37646204 | - |
dc.identifier.scopus | 2-s2.0-85172690945 | - |
dc.identifier.url | https://api.elsevier.com/content/abstract/scopus_id/85172690945 | - |
item.fulltext | no fulltext | - |
item.cerifentitytype | Publications | - |
item.openairecristype | http://purl.org/coar/resource_type/c_6501 | - |
item.grantfulltext | none | - |
item.openairetype | journal article | - |
item.languageiso639-1 | en | - |
crisitem.author.dept | Laboratory Medicine | - |
crisitem.author.dept | Laboratory Medicine-NTUH | - |
crisitem.author.dept | Institute of Health Data Analytics and Statistics | - |
crisitem.author.dept | Master of Public Health Degree Program | - |
crisitem.author.orcid | 0000-0002-7502-9225 | - |
crisitem.author.orcid | 0000-0002-2461-474X | - |
crisitem.author.parentorg | College of Medicine | - |
crisitem.author.parentorg | National Taiwan University Hospital | - |
crisitem.author.parentorg | College of Public Health | - |
crisitem.author.parentorg | College of Public Health | - |
Appears in Collections: | 醫學院附設醫院 (臺大醫院) |
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.